North America Cardiac Microcatheter Market Forecast to 2028

North America Cardiac Microcatheter Market Forecast to 2028 – Regional Analysis – by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

Send Enquiry

$2,485$3,500

Description

The North America cardiac microcatheter market is expected to grow from US$ 134.79 million in 2023 to US$ 188.10 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.

Increasing Prevalence of Cardiovascular Diseases Fuel North America Cardiac Microcatheter Market

According to the World Health Organization (WHO), cardiovascular diseases are the most prominent cause of morbidity and mortality worldwide. cardiovascular diseases include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Major lifestyle factors causing cardiovascular diseases and related difficulties are tobacco consumption, unhealthy diet, and physical inactivity, among others. The other risk factors related to cardiovascular diseases are high blood pressure, diabetes, and elevated cholesterol levels. Heart attacks and strokes are mainly caused by fatty deposits that block blood vessels, disrupting blood flow to the heart or brain. According to a report from American Heart Association, in 2020, ~19 million deaths were attributed to cardiovascular diseases globally, which amounted to an increase of 18.7% from 2010. Ischemic heart disease was the most common cause of cardiovascular mortality, claiming more than 9.4 million lives and 185 million disability-adjusted life-years in 2020, while ischemic stroke, intracerebral hemorrhage, hypertensive heart disease, and rheumatic heart disease rounded out to be the top 5 leading causes. According to American Heart Association Inc., the cardiovascular diseases -related deaths recorded in 2020 increased to 928,741 from 874,613 in 2019. Between 2018 and 2019, direct and indirect costs of total cardiovascular diseases were US$ 407.3 billion (US$ 251.4 billion in direct costs and US$ 155.9 billion in lost productivity/mortality). In 2020, coronary heart disease was the leading cause (41.2%) of deaths attributable to cardiovascular diseases in the US, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%), and other cardiovascular diseases (16.8%). Also, the World Heart Federation predicts more than 23 million cardiovascular diseases -related deaths per year by 2030. Therefore, the high prevalence of cardiovascular diseases is boosting the North America cardiac microcatheter market.

North America Cardiac Microcatheter Market Overview

The North America cardiac microcatheter market is segmented into the US, Canada, and Mexico. The market growth in countries such as the US and Canada is driven by factors such as increasing incidence of heart diseases, including cardiovascular disorders, stroke, and others, coupled with well-developed healthcare infrastructure.

North America Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiac Microcatheter Market Segmentation

The North America cardiac microcatheter market is segmented into indication, end user, and country.

Based on indication, the North America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the North America cardiac microcatheter market in 2023.

Based on end user, the North America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the North America cardiac microcatheter market in 2023.

Based on country, the North America cardiac microcatheter market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America cardiac microcatheter market in 2023.

Asahi Intecc USA Inc; Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; Teleflex Inc; and Terumo Corp are the leading companies operating in the North America cardiac microcatheter market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 6.9% CAGR, the North America Cardiac Microcatheter Market is speculated to be worth US$ 188.10 million by 2028, says The Research Team

According to The Research Team’ research, the North America cardiac microcatheter market was valued at US$ 134.79 million in 2023 and is expected to reach US$ 188.10 million by 2028, registering a CAGR of 6.9% from 2023 to 2028. High prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO) are the critical factors attributed to the North America cardiac microcatheter market expansion.

Percutaneous coronary intervention (PCI) is one of the most difficult procedures for treating of chronic total occlusions (CTO), resulting in successful recanalization of CTO. CTOPCIs represent 4% of all PCIs for stable angina in the US. Further, CTO is complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. As per the National Heart, Lung, and Blood Institute, CTOs are found in approximately one-third of patients undergoing angiography. Significant progress has been made in this area over the past decade, given the novel product launches and approvals. However, the launch of new technical devices and strategic refinements are still being monitored in the procedures to combat CTOs as the microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and CTO. Terumo’s FineCross MG microcatheter integrates cross ability and guidewire support for treating challenging cases including tortuous vessels, CTOs, bifurcations, as well as severely stenosed and calcified lesions. Therefore, the growing usage of PCIs for treating CTO is catalyzing the North America cardiac microcatheter market growth.

On the contrary, complications and failures related to usage of cardiac microcatheters hampers the North America Cardiac Microcatheter Market.

Based on indication, the North America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held 58.2% share of North America Cardiac Microcatheter Market in 2023, amassing US$ 78.41 million. It is projected to garner US$ 110.35 million by 2028 to expand at 7.1% CAGR during 2023–2028.

Based on end user, the North America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held 44.7% share of North America Cardiac Microcatheter Market in 2023, amassing US$ 60.23 million. It is projected to garner US$ 85.39 million by 2028 to expand at 7.2% CAGR during 2023–2028.

Based on country, the North America cardiac microcatheter market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 78.6% share of North America Cardiac Microcatheter Market in 2023. It was assessed at US$ 105.95 million in 2023 and is likely to hit US$ 148.81 million by 2028, exhibiting a CAGR of 7.0% during the forecast period.

Key players dominating the North America cardiac microcatheter market are Asahi Intecc USA Inc; Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; Teleflex Inc; and Terumo Corp, among others.

In February 2022, Teleflex Incorporated, a leading global provider of medical technologies, announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI). In July 2021, Terumo Medical Corporation (TMC) announced AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo’s robust embolization portfolio is indicated for use to reduce or block the blood flow rate in peripheral vasculature arteries.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America cardiacmicrocatheter market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America cardiacmicrocatheter market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cardiac Microcatheter Market – by Indication
1.3.2 North America Cardiac Microcatheter Market – by End User
1.3.3 North America Cardiac Microcatheter Market – by Country
2. North America Cardiac Microcatheter Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cardiac Microcatheter Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts’ Opinion
5. North America Cardiac Microcatheter Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
5.2 Market Restraints
5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheter
5.3 Market Opportunity
5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
5.4 Future Trends
5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter
5.5 Impact Analysis of Drivers and Restraints
6. Cardiac Microcatheter Market – North America Analysis
6.1 North America Cardiac Microcatheter Market Revenue Forecast and Analysis
7. North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 – by Indication
7.1 Overview
7.2 Coronary
7.2.1 Overview
7.2.2 Coronary: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
7.3 General Peripheral Vascular
7.3.1 Overview
7.3.2 General Peripheral Vascular: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Cardiac Microcatheter Market Analysis – by End User
8.1 Overview
8.2 Hospitals
8.2.1 Overview
8.2.2 Hospitals: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Ambulatory Surgical Centers
8.3.1 Overview
8.3.2 Ambulatory Surgical Centers: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Specialty Clinics
8.4.1 Overview
8.4.2 Specialty Clinics: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1 North America Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
9.1.1.1 US: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 US: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 US: North America Cardiac Microcatheter Market, by Indication, 2020–2028 (US$ Million)
9.1.1.1.4 US: North America Cardiac Microcatheter Market, by End User, 2020–2028 (US$ Million)
9.1.1.2 Canada: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Canada: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 Canada: North America Cardiac Microcatheter Market, by Indication, 2020–2028 (US$ Million)
9.1.1.2.4 Canada: North America Cardiac Microcatheter Market, by End User, 2020–2028 (US$ Million)
9.1.1.3 Mexico: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 Mexico: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 Mexico: North America Cardiac Microcatheter Market, by Indication, 2020–2028 (US$ Million)
9.1.1.3.4 Mexico: North America Cardiac Microcatheter Market, by End User, 2020–2028 (US$ Million)
10. North America Cardiac Microcatheter Market – Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
11. Company Profiles
11.1 Boston Scientific Corp
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Teleflex Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Medtronic Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Asahi Intecc USA Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Merit Medical Systems Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Nipro Corp
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Terumo Corp
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Integer Holdings Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Research Team
12.2 Glossary of Terms

LIST OF TABLES

Table 1.             US North America Cardiac Microcatheter Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 2.             US North America Cardiac Microcatheter Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 3.             Canada North America Cardiac Microcatheter Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 4.             Canada North America Cardiac Microcatheter Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5.             Mexico North America Cardiac Microcatheter Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Mexico North America Cardiac Microcatheter Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7.             Organic Developments Done by Companies
Table 8.             Glossary of Terms
 
 

LIST OF FIGURES

Figure 1.           North America Cardiac Microcatheter Market Segmentation
Figure 2.           North America Cardiac Microcatheter Market by Country
Figure 3.           North America Cardiac Microcatheter Market Overview
Figure 4.           Coronary Held Largest Share of Indication Segment in North America Cardiac Microcatheter Market
Figure 5.           North America Cardiac Microcatheter Market – Leading Country Markets (US$ Million)
Figure 6.           North America PEST Analysis
Figure 7.           North America Cardiac Microcatheter Market Impact Analysis of Drivers and Restraints
Figure 8.           North America Cardiac Microcatheter Market – Revenue Forecast and Analysis – 2020–2028
Figure 9.           North America Cardiac Microcatheter Market Revenue Share, by Indication, 2022 & 2028 (%)
Figure 10.        Coronary: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11.        General Peripheral Vascular: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12.        North America Cardiac Microcatheter Market Revenue Share, by End User, 2022 & 2028 (%)
Figure 13.        Hospitals: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14.        Ambulatory Surgical Centers: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15.        Specialty Clinics: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16.        North America Cardiac Microcatheter Market, by Key Country – Revenue (2022) (US$ Million)
Figure 17.        North America Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
Figure 18.        US: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19.        Canada: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20.        Mexico: North America Cardiac Microcatheter Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – North America Cardiac Microcatheter Market

o Asahi Intecc USA Inc
o Boston Scientific Corp
o Integer Holdings Corp
o Medtronic Plc
o Merit Medical Systems Inc
o Nipro Corp
o Teleflex Inc
o Terumo Corp

Reviews

There are no reviews yet.

Be the first to review “North America Cardiac Microcatheter Market Forecast to 2028”